BOROSCI

Borosil Scientific Limited

Industrial glass products and services provider is not correct as per rules

Industrials›Capital Goods›Industrial Products›Glass - Industrial

borosilscientific.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹107.42
Market cap
955 Cr
Stock P/E
22.1
P/B
2.16
ROE (FY26)
7.8%
ROCE (FY26)
9.8%
Operating margin (FY26)
9.2%
Debt / equity (FY26)
0.02
OCF / EBITDA (FY26)
69.6%
OCF / EBITDA (3Y)
120.8%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Borosil Scientific makes laboratory glassware, lab equipment and process systems for laboratories, universities and industry in India, along with glass ampoules and tubular vials that pharmaceutical companies use as primary packaging for injectables.

Company snapshot

3rdBy market cap

Ranked among 3 companies in Glass - Industrial.

Segment mix

Reportable segments as of 2024-12-31 (Consolidated). Revenue share = segment revenue ÷ total revenue.

Largest segment: 69.5% of revenue

SegmentRevenue shareRevenuePBTAssets
Glassware
29.3%
30 Cr-5 Cr110 Cr
Others
1.2%
1 Cr0.37 Cr2 Cr
Scientific – Laboratory Glass & equipment and Process System
69.5%
71 Cr15 Cr204 Cr

What we see

Positives
  • ✓121% of operating profit came in as cash over the last three years — profits are backed by real cash.
2 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricMar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales115 Cr104 Cr103 Cr101 Cr129 Cr96 Cr107 Cr121 Cr143 Cr107 Cr
Operating expenses (approx.)97 Cr94 Cr87 Cr91 Cr113 Cr91 Cr99 Cr104 Cr111 Cr98 Cr
EBITDA18 Cr10 Cr15 Cr10 Cr17 Cr5 Cr8 Cr17 Cr32 Cr8 Cr
OPM %15.5%9.4%15.1%9.9%12.8%5.1%7.5%14.2%22.4%7.9%
Other income2 Cr2 Cr2 Cr2 Cr3 Cr3 Cr2 Cr2 Cr2 Cr3 Cr
Interest0.67 Cr0.40 Cr0.36 Cr0.35 Cr0.44 Cr0.38 Cr0.23 Cr0.26 Cr0.26 Cr0.25 Cr
Depreciation4 Cr5 Cr5 Cr5 Cr5 Cr5 Cr5 Cr5 Cr5 Cr5 Cr
Profit before tax15 Cr7 Cr12 Cr7 Cr14 Cr-4 Cr5 Cr13 Cr29 Cr6 Cr
Tax %35.3%28.5%29.1%38.3%38.6%-3.1%44.5%31.2%6.5%27.2%
Net profit9 Cr5 Cr9 Cr4 Cr9 Cr-4 Cr3 Cr9 Cr27 Cr4 Cr
EPS (₹)₹1.05₹0.57₹0.99₹0.48₹0.98₹-0.47₹0.32₹0.98₹3.06₹0.49

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2024Mar 2025Mar 2026TTM
Sales395 Cr438 Cr467 CrSign in free for the trailing twelve months
Operating expenses (approx.)349 Cr386 Cr405 CrSign in free for the trailing twelve months
EBITDA45 Cr53 Cr62 CrSign in free for the trailing twelve months
OPM %11.5%12.0%13.3%Sign in free for the trailing twelve months
Other income5 Cr8 Cr10 CrSign in free for the trailing twelve months
Interest3 Cr2 Cr1 CrSign in free for the trailing twelve months
Depreciation16 Cr18 Cr19 CrSign in free for the trailing twelve months
Profit before tax32 Cr40 Cr43 CrSign in free for the trailing twelve months
Tax %25.6%33.8%19.3%Sign in free for the trailing twelve months
Net profit23 Cr27 Cr35 CrSign in free for the trailing twelve months
EPS (₹)₹2.65₹3.02₹3.89Sign in free for the trailing twelve months
Dividend payout %0.0%0.0%0.0%Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2024Mar 2025Mar 2026
Equity capital9 Cr9 Cr9 Cr
Reserves367 Cr395 Cr432 Cr
Borrowings17 Cr14 Cr8 Cr
Other liabilities100 Cr90 Cr100 Cr
Total liabilities493 Cr509 Cr549 Cr
Fixed assets (net)124 Cr120 Cr122 Cr
CWIP0.83 Cr1 Cr9 Cr
Investments0.01 Cr105 Cr122 Cr
Loans & advances0.24 Cr0.19 Cr0.55 Cr
Inventories97 Cr97 Cr103 Cr
Trade receivables61 Cr71 Cr76 Cr
Cash & bank12 Cr13 Cr13 Cr
Other assets198 Cr101 Cr104 Cr
Total assets493 Cr509 Cr549 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2024Mar 2025Mar 2026
Cash from operating activity30 Cr120 Cr43 Cr
Cash from investing-2 Cr-115 Cr-37 Cr
Cash from financing-16 Cr-3 Cr-6 Cr
Net cash flow12 Cr1 Cr-0.15 Cr
Free cash flow (OCF − Capex)17 Cr106 Cr15 Cr

Ratios

MetricMar 2024Mar 2025Mar 2026
ROCE %8.7%10.0%9.8%
ROE %6.3%6.6%7.8%
Debtor days575959
Inventory days275245237
Days payable1158898
Cash conversion cycle217215199
OCF / EBITDA %66.3%228.2%69.6%
OCF / EBITDA % (3 years)——120.8%
Debt / equity0.040.030.02
Current ratio2.913.563.62
Net debt / EBITDA0.100.02-0.08